[在川崎病中的冠状动脉再血管]
Carolina Cabrera-Cerna1, Gabriela Bustillos-García2, Juan Calderón-Colmenero2
1Médico residente de Cardiología Pediátrica. Instituto Nacional de Cardiología Ignacio Chávez, México. Médico residente de Cardiología Pediátrica. Instituto Nacional de Cardiología Ignacio Chávez México.
概括
川崎病 (KD) 是儿童获得性心脏病的主要原因,经常导致冠状动脉瘤. 这一案例证明了儿童患者在KD引起的严重冠状动脉疾病中成功进行手术重血管化.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 心血管外科心血管外科
- 类风湿病学 类风湿病学
背景情况:
- 川崎病 (KD) 是许多国家的儿童获得心脏病的主要原因.
- 冠状动脉动脉瘤是KD最严重的并发症.
- 早期诊断和管理对于预防长期心脏病后果至关重要.
研究的目的:
- 报告一个成功的手术重血管化的案例,在一个患有复杂冠状动脉疾病的儿科患者中,该患者的冠状动脉疾病是川崎病的次要原因.
- 突出及时手术干预在管理KD诱导的冠状动脉并发症的重要性.
主要方法:
- 一名患有三血管冠状动脉疾病的5岁患者因KD而经历了冠状动脉旁路移植.
- 移植包括左内乳腺动脉到前下降动脉,右乳腺动脉到边缘 obtuse 动脉,以及辐射动脉到后下降动脉.
主要成果:
- 患者经历了一次成功的重血管化手术.
- 手术的目的是防止心脏不良事件,如心室功能障碍,心律失常,心脏病发作和突然死亡.
结论:
- 在患有川崎病的儿科患者中,手术重血管化可以成为严重冠状动脉疾病的成功治疗选择.
- 密切监测和适当的手术时间是预防与KD相关的冠状动脉并发症相关的长期残疾和死亡率的关键.
相关概念视频
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...


